non-small cell lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) diagnosed with cytologically histologically proven non-small cell lung cancer, TNM stage IIB above; (2) have received chemotherapy with the TP (paclitaxel + cisplatin) and DP (dorsey he + cisplatin); (3) psychological distress thermometer scored 4 points or more; (4) known their own disease diagnosis; (5) expected to live 3 months or more; (6) with conscious, be able to understand and cooperate with intervention methods, Without a hearing and language communication obstacles; (7) the patient and family to informed the consent of this study and agreed to take part.
Exclusion criteria
Exclusion criteria: (1) PS score > 2 points; (2) The pain digital score> 4 points continuous , need analgesics; (3) with severe primary diseases such as liver, kidney, hematopoietic,endocrine system etc; (4) had a history of mental illness, history of personality disorders, cognitive dysfunction and brain organic disease patients; (5) has been a brain metastasis and nerve injury to produce cognitive behavioral disorder; (6) havesserious organ failure patients; (7) has a history of music epilepsy and sensitive to music, cnnot able to tolerance; ? (8) undergoing hospital other clinical subjects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Distress Thermometer;Hospital Anxiety and Depression Scale, HADS; | — |
Secondary
| Measure | Time frame |
|---|---|
| EORTC QLQ-LC43;Cancer Coping Modes Questionnaire, CCMQ;Pittsburgh sleep quality inde, PSQI; | — |
Countries
China
Contacts
Chengdu University of TCM